CoChat

TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels

Open access
Hong, Shengjun, Dobricic, Valerija, Ohlei, Olena, Bos, Isabelle, Vos, Stephanie J. B., Prokopenko, Dmitry, Tijms, Betty M., Andreasson, Ulf, Blennow, Kaj, Vandenberghe, Rik, Gabel, Silvy, Scheltens, Philip, Teunissen, Charlotte E., Engelborghs, Sebastiaan, Frisoni, Giovanni, Blin, Olivier, Richardson, Jill C., Bordet, Regis, Alzheimer's Disease Neuroimaging Initiative (ADNI), Lleó, Alberto, Alcolea, Daniel, Popp, Julius, Clark, Christopher, Peyratout, Gwendoline, Martinez‐Lage, Pablo, Tainta, Mikel, Dobson, Richard J. B., Legido‐Quigley, Cristina, Sleegers, Kristel, Van Broeckhoven, Christine, Tanzi, Rudolph E., ten Kate, Mara, Wittig, Michael, Franke, Andre, Lill, Christina M., Barkhof, Frederik, Lovestone, Simon, Streffer, Johannes, Zetterberg, Henrik, Visser, Pieter Jelle, Bertram, Lars · 2021 · Alzheimer's & Dementia
Cited by 37

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Introduction: Neurofilament light (NfL), chitinase‐3‐like protein 1 (YKL‐40), and neurogranin (Ng) are biomarkers for Alzheimer's disease (AD) to monitor axonal damage, astroglial activation, and synaptic degeneration, respectively. Methods: We performed genome‐wide association studies (GWAS) using DNA and cerebrospinal fluid (CSF) samples from the EMIF‐AD Multimodal Biomarker Discovery study for discovery, and the Alzheimer's Disease Neuroimaging Initiative study for validation analyses. GWAS were performed for all three CSF biomarkers using linear regression models adjusting for relevant covariates. Results: We identify novel genome‐wide significant associations between DNA variants in TMEM106B and CSF levels of NfL, and between CPOX and YKL‐40. We confirm previous work suggesting that YKL‐40 levels are associated with DNA variants in CHI3L1 . Discussion: Our study provides important new insights into the genetic architecture underlying interindividual variation in three AD‐related CSF biomarkers. In particular, our data shed light on the sequence of events regarding the initiation and progression of neuropathological processes relevant in AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.12330

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

Metadata

Authors
Hong, S., Dobricic, V., Ohlei, O., Bos, I., Vos, S. J. B., Prokopenko, D., Tijms, B. M., Andreasson, U., Blennow, K., Vandenberghe, R., Gabel, S., Scheltens, P., Teunissen, C. E., Engelborghs, S., Frisoni, G., Blin, O., Richardson, J. C., Bordet, R., (ADNI), A. D. N. I., Lleó, A., Alcolea, D., Popp, J., Clark, C., Peyratout, G., Martinez‐Lage, P., Tainta, M., Dobson, R. J. B., Legido‐Quigley, C., Sleegers, K., Van Broeckhoven, C., Tanzi, R. E., ten Kate, M., Wittig, M., Franke, A., Lill, C. M., Barkhof, F., Lovestone, S., Streffer, J., Zetterberg, H., Visser, P. J., & Bertram, L.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2021-05-14
Volume
17
Issue
10
Pages
1628-1640
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W3160827273
Cited by
37
References
23
FWCI
3.79
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.